Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study
01 oct. 2024 08h00 HE
|
Halberd Corp.
Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
11 sept. 2024 08h00 HE
|
Halberd Corp.
Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD
Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
09 sept. 2024 09h31 HE
|
Halberd Corp.
Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
04 sept. 2024 08h00 HE
|
Halberd Corp.
Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction
Halberd Corp. Issues Letter to Shareholders
26 août 2024 08h00 HE
|
Halberd Corp.
Halberd Corp. - Taking a Moment to Recenter Our Technical Progress
Halberd Corp’s (OTC: HALB) Groundbreaking Traumatic Brain Injury (TBI) Mitigation Nasal Spray Shows Promising Phase II Initial Test Results
24 juil. 2024 08h00 HE
|
Halberd Corp.
Halberd Corp’s (OTC: HALB) Groundbreaking Traumatic Brain Injury (TBI) Mitigation Nasal Spray Shows Promising Phase II Initial Test Results